These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 25585848)

  • 1. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
    Kaufmann S; Schulze M; Spira D; Horger M
    Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation.
    Kaufmann S; Horger T; Oelker A; Beck S; Schulze M; Nikolaou K; Ketelsen D; Horger M
    Eur J Radiol; 2015 Dec; 84(12):2548-54. PubMed ID: 26428842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration.
    Thaiss WM; Haberland U; Kaufmann S; Hepp T; Schulze M; Blum AC; Ketelsen D; Nikolaou K; Horger M; Sauter AW
    Acad Radiol; 2019 Sep; 26(9):1154-1163. PubMed ID: 30482626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
    Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trial.
    Syha R; Gatidis S; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
    Cancer Imaging; 2016 Sep; 16(1):30. PubMed ID: 27654658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study.
    Wiggermann P; Wohlgemuth WA; Heibl M; Vasilj A; Loss M; Schreyer AG; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2013; 53(4):337-48. PubMed ID: 22555335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
    World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Rathmann N; Kara K; Budjan J; Henzler T; Smakic A; Schoenberg SO; Diehl SJ
    Anticancer Res; 2017 Oct; 37(10):5681-5685. PubMed ID: 28982886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma.
    Park KH; Kwon SH; Lee YS; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ
    Clin Mol Hepatol; 2015 Jun; 21(2):158-64. PubMed ID: 26157753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
    Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
    Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results.
    Wobser H; Wiest R; Salzberger B; Wohlgemuth WA; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2014; 57(2):191-201. PubMed ID: 24577382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography.
    Paul SB; Dhamija E; Gamanagatti SR; Sreenivas V; Yadav DP; Jain S; Shalimar ; Acharya SK
    Diagn Interv Imaging; 2017 Mar; 98(3):253-260. PubMed ID: 27692674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease control.
    Tamandl D; Waneck F; Sieghart W; Unterhumer S; Kölblinger C; Baltzer P; Ba-Ssalamah A; Loewe C
    Eur J Radiol; 2017 May; 90():73-80. PubMed ID: 28583650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
    Wimmer T; Steiner J; Talakic E; Stauber R; Quehenberger F; Portugaller RH; Schoellnast H
    J Comput Assist Tomogr; 2017; 41(5):708-712. PubMed ID: 28296685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series.
    Lekht I; Nayyar M; Luu B; Guichet PL; Ho J; Ter-Oganesyan R; Katz M; Gulati M
    Abdom Radiol (NY); 2017 May; 42(5):1400-1407. PubMed ID: 28008454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early evaluation of treatment response to transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The role of dynamic three-dimensional contrast-enhanced ultrasound.
    Cao J; Dong Y; Fan P; Mao F; Chen K; Chen R; Huang B; Cheng Y; Wang WP
    Clin Hemorheol Microcirc; 2021; 78(4):365-377. PubMed ID: 33682701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound.
    Tian H; Wang Q
    Eur J Cancer; 2016 Nov; 68():82-89. PubMed ID: 27728840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.